These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

478 related articles for article (PubMed ID: 19942925)

  • 1. Histological and molecular types of breast cancer: is there a unifying taxonomy?
    Weigelt B; Reis-Filho JS
    Nat Rev Clin Oncol; 2009 Dec; 6(12):718-30. PubMed ID: 19942925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histological types of breast cancer: how special are they?
    Weigelt B; Geyer FC; Reis-Filho JS
    Mol Oncol; 2010 Jun; 4(3):192-208. PubMed ID: 20452298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast cancer special types: why bother?
    Reis-Filho JS; Lakhani SR
    J Pathol; 2008 Dec; 216(4):394-8. PubMed ID: 18798222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Refinement of breast cancer classification by molecular characterization of histological special types.
    Weigelt B; Horlings HM; Kreike B; Hayes MM; Hauptmann M; Wessels LF; de Jong D; Van de Vijver MJ; Van't Veer LJ; Peterse JL
    J Pathol; 2008 Oct; 216(2):141-50. PubMed ID: 18720457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The differences in the histological types of breast cancer and the response to neoadjuvant chemotherapy: the relationship between the outcome and the clinicopathological characteristics.
    Nagao T; Kinoshita T; Hojo T; Tsuda H; Tamura K; Fujiwara Y
    Breast; 2012 Jun; 21(3):289-95. PubMed ID: 22277312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast cancer prognostic classification in the molecular era: the role of histological grade.
    Rakha EA; Reis-Filho JS; Baehner F; Dabbs DJ; Decker T; Eusebi V; Fox SB; Ichihara S; Jacquemier J; Lakhani SR; Palacios J; Richardson AL; Schnitt SJ; Schmitt FC; Tan PH; Tse GM; Badve S; Ellis IO
    Breast Cancer Res; 2010; 12(4):207. PubMed ID: 20804570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microarrays in the 2010s: the contribution of microarray-based gene expression profiling to breast cancer classification, prognostication and prediction.
    Colombo PE; Milanezi F; Weigelt B; Reis-Filho JS
    Breast Cancer Res; 2011 Jun; 13(3):212. PubMed ID: 21787441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microarray-based gene expression profiling as a clinical tool for breast cancer management: are we there yet?
    Correa Geyer F; Reis-Filho JS
    Int J Surg Pathol; 2009 Aug; 17(4):285-302. PubMed ID: 19103611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological characteristics and prognosis of breast cancer with special histological types: A surveillance, epidemiology, and end results database analysis.
    Han Y; Wang J; Xu B
    Breast; 2020 Dec; 54():114-120. PubMed ID: 32979771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast cancer pathology: the impact of molecular taxonomy on morphological taxonomy.
    Masuda S
    Pathol Int; 2012 May; 62(5):295-302. PubMed ID: 22524656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of molecular analysis in breast cancer.
    Geyer FC; Marchio C; Reis-Filho JS
    Pathology; 2009 Jan; 41(1):77-88. PubMed ID: 19089743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular classification of breast cancer.
    Vuong D; Simpson PT; Green B; Cummings MC; Lakhani SR
    Virchows Arch; 2014 Jul; 465(1):1-14. PubMed ID: 24878755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The classification of invasive carcinoma of the breast.
    Gannon LM; Cotter MB; Quinn CM
    Expert Rev Anticancer Ther; 2013 Aug; 13(8):941-54. PubMed ID: 23984896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular Biological Features of Nottingham Histological Grade 3 Breast Cancers.
    Takahashi H; Oshi M; Asaoka M; Yan L; Endo I; Takabe K
    Ann Surg Oncol; 2020 Oct; 27(11):4475-4485. PubMed ID: 32436191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uptake and washout of 99mTcV-dimercaptosuccinic acid and 99mTc-sestamibi in the assessment of histological type and grade in breast cancer.
    Papantoniou V; Christodoulidou J; Papadaki E; Valotassiou V; Souvatzoglou M; Louvrou A; Feida H; Sotiropoulou M; Pampouras G; Michalas S; Zerva C
    Nucl Med Commun; 2002 May; 23(5):461-7. PubMed ID: 11973487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Classification and grading of invasive breast carcinoma.
    Elston CW
    Verh Dtsch Ges Pathol; 2005; 89():35-44. PubMed ID: 18035670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Molecular taxonomy of luminal breast cancer in 2015].
    Franchet C; Duprez-Paumier R; Lacroix-Triki M
    Bull Cancer; 2015 Jun; 102(6 Suppl 1):S34-46. PubMed ID: 26118875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Classification of ductal carcinoma in situ by gene expression profiling.
    Hannemann J; Velds A; Halfwerk JB; Kreike B; Peterse JL; van de Vijver MJ
    Breast Cancer Res; 2006; 8(5):R61. PubMed ID: 17069663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant therapies for special types of breast cancer.
    Colleoni M; Russo L; Dellapasqua S
    Breast; 2011 Oct; 20 Suppl 3():S153-7. PubMed ID: 22015285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The molecular basis of breast cancer pathological phenotypes.
    Heng YJ; Lester SC; Tse GM; Factor RE; Allison KH; Collins LC; Chen YY; Jensen KC; Johnson NB; Jeong JC; Punjabi R; Shin SJ; Singh K; Krings G; Eberhard DA; Tan PH; Korski K; Waldman FM; Gutman DA; Sanders M; Reis-Filho JS; Flanagan SR; Gendoo DM; Chen GM; Haibe-Kains B; Ciriello G; Hoadley KA; Perou CM; Beck AH
    J Pathol; 2017 Feb; 241(3):375-391. PubMed ID: 27861902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.